News

Net profit of Solara Active Pharma Sciences rose 55.04% to Rs 16.31 crore in the quarter ended June 2026 as against Rs 10.52 crore during the previous quarter ended June 2025. Sales rose 19.57% to Rs 381.60 crore in the quarter ended June 2026 as against Rs 319.15 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales381.60319.15 20 OPM %16.2417.87 - PBDT43.0234.10 26 PBT16.3110.52 55 NP16.3110.52 55 Powered by Capital Market - Live News

Solara Active Pharma Sciences has appointed Ajit Manocha as Chief Information Officer (CIO) with effect from 10 August 2026.

Solara Active Pharma Sciences will hold a meeting of the Board of Directors of the Company on 23 July 2026.

Solara Active Pharma Sciences has allotted 2,200 equity shares under ESOP on 15 May 2026. With this allotment, the paid up equity share capital has increased to 4,81,73,762 equity shares at Rs. 10/- each.

Net profit of Solara Active Pharma Sciences reported to Rs 9.60 crore in the quarter ended March 2026 as against net loss of Rs 2.10 crore during the previous quarter ended March 2025. Sales rose 41.86% to Rs 387.29 crore in the quarter ended March 2026 as against Rs 273.01 crore during the previous quarter ended March 2025.For the full year,net loss reported to Rs 7.41 crore in the year ended March 2026 as against net profit of Rs 0.54 crore during the previous year ended March 2025. Sales rose 6.64% to Rs 1368.98 crore in the year ended March 2026 as against Rs 1283.76 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales387.29273.01 42 1368.981283.76 7 OPM %14.8916.62 -13.6416.07 - PBDT34.7822.20 57 98.1699.79 -2 PBT8.74-2.10 LP -1.520.54 PL NP9.60-2.10 LP -7.410.54 PL Powered by Capital Market - Live News